BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34773560)

  • 1. A contemporary clinical approach to genetic testing for heritable hyperparathyroidism syndromes.
    De Sousa SMC; Carroll RW; Henderson A; Burgess J; Clifton-Bligh RJ
    Endocrine; 2022 Jan; 75(1):23-32. PubMed ID: 34773560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort.
    Mariathasan S; Andrews KA; Thompson E; Challis BG; Wilcox S; Pierce H; Hale J; Spiden S; Fuller G; Simpson HL; Fish B; Jani P; Seetho I; Armstrong R; Izatt L; Joshi M; Velusamy A; Park SM; Casey RT
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):409-418. PubMed ID: 32430905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.
    Stratta P; Merlotti G; Musetti C; Quaglia M; Pagani A; Izzo C; Radin E; Airoldi A; Baorda F; Palladino T; Leone MP; Guarnieri V
    Nephrol Dial Transplant; 2014 Oct; 29(10):1902-9. PubMed ID: 25104082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences.
    Vargas-Poussou R; Mansour-Hendili L; Baron S; Bertocchio JP; Travers C; Simian C; Treard C; Baudouin V; Beltran S; Broux F; Camard O; Cloarec S; Cormier C; Debussche X; Dubosclard E; Eid C; Haymann JP; Kiando SR; Kuhn JM; Lefort G; Linglart A; Lucas-Pouliquen B; Macher MA; Maruani G; Ouzounian S; Polak M; Requeda E; Robier D; Silve C; Souberbielle JC; Tack I; Vezzosi D; Jeunemaitre X; Houillier P
    J Clin Endocrinol Metab; 2016 May; 101(5):2185-95. PubMed ID: 26963950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods.
    Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Brixen K; Mosekilde L
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):713-20. PubMed ID: 18410554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of Clinical Genetic Testing in Patients with Features Suggestive for Hereditary Predisposition to PTH-Mediated Hypercalcemia.
    Khairi S; Osborne J; Jacobs MF; Clines GT; Miller BS; Hughes DT; Else T
    Horm Cancer; 2020 Oct; 11(5-6):250-255. PubMed ID: 32761341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
    Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
    Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stepwise CaSR, AP2S1, and GNA11 sequencing in patients with suspected familial hypocalciuric hypercalcemia.
    Szalat A; Shpitzen S; Tsur A; Zalmon Koren I; Shilo S; Tripto-Shkolnik L; Durst R; Leitersdorf E; Meiner V
    Endocrine; 2017 Mar; 55(3):741-747. PubMed ID: 28176280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic testing for familial hyperparathyroidism: clinical-genetic profile in a Mediterranean cohort.
    Mazarico-Altisent I; Capel I; Baena N; Bella-Cueto MR; Barcons S; Guirao X; Pareja R; Muntean A; Arsentales V; Caixàs A; Rigla M
    Front Endocrinol (Lausanne); 2023; 14():1244361. PubMed ID: 37810884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent hypercalcemia with similar familial Hypocalciuric hypercalcemia features: a case report and literature review.
    Zahedi M; Hizomi Arani R; Rafati M; Amouzegar A; Hadaegh F
    BMC Endocr Disord; 2021 Nov; 21(1):220. PubMed ID: 34736428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial Hyperparathyroidism - Disorders of Growth and Secretion in Hormone-Secretory Tissue.
    Marx SJ; Lourenço DM
    Horm Metab Res; 2017 Nov; 49(11):805-815. PubMed ID: 29136674
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Szalat A; Shpitzen S; Pollack R; Mazeh H; Durst R; Meiner V
    Front Endocrinol (Lausanne); 2023; 14():1254156. PubMed ID: 38130397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and outcome comparison of genetically positive vs. negative patients in a large cohort of suspected familial hypocalciuric hypercalcemia.
    Asla Q; Sardà H; Seguí N; Martínez de Pinillos G; Mazarico-Altisent I; Capel I; Rives J; Suárez J; Ávila-Rubio V; Muñoz Torres M; Saigí I; Palacios N; Urgell E; Webb SM; Fernández M; Oriola J; Mora M; Tondo M; Aulinas A
    Endocrine; 2024 Mar; 83(3):747-756. PubMed ID: 38214877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel CASR variant in a family with familial hypocalciuric hypercalcaemia and primary hyperparathyroidism.
    Sagi SV; Joshi H; Trotman J; Elsey T; Swamy A; Rajkanna J; Bhat NA; Haddadin FJS; Oyibo SO; Park SM
    Endocrinol Diabetes Metab Case Rep; 2020 Sep; 2020():. PubMed ID: 33434173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of familial hypocalciuric hypercalcemia type 1 due to CASR p.Pro55Leu mutation.
    Sumida A; Iizuka K; Kato T; Liu Y; Kubota S; Kubota-Okamoto S; Sakurai T; Imaizumi T; Takahashi Y; Mizuno M; Takao K; Hirota T; Suwa T; Horikawa Y; Yamamoto M; Seino Y; Suzuki A; Yabe D
    BMC Endocr Disord; 2022 Jun; 22(1):164. PubMed ID: 35733207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathogenesis of primary hyperparathyroidism.
    Cetani F; Pardi E; Borsari S; Marcocci C
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):35-9. PubMed ID: 21985978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial hypocalciuric hypercalcaemia type 1 caused by a novel heterozygous missense variant in the CaSR gene, p(His41Arg): two case reports.
    Courtney A; Hill A; Smith D; Agha A
    BMC Endocr Disord; 2022 Dec; 22(1):324. PubMed ID: 36536367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary calcium indices in primary hyperparathyroidism (PHPT) and familial hypocalciuric hypercalcaemia (FHH): which test performs best?
    Arshad MF; McAllister J; Merchant A; Rab E; Cook J; Eastell R; Balasubramanian S
    Postgrad Med J; 2021 Sep; 97(1151):577-582. PubMed ID: 32892159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation of the calcium-sensing receptor gene in a German subject with familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
    Papadakis M; Meurer N; Margariti T; Meyer A; Weyerbrock N; Dotzenrath C
    Hormones (Athens); 2016 Oct; 15(4):557-559. PubMed ID: 28222409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A series of clinical cases of familial hypocalciuric hypercalcemia syndrome].
    Krupinova JA; Almaskhanova AA; Eremkina AK; Bibik EE; Vasilyev EV; Mokrysheva NG
    Probl Endokrinol (Mosk); 2020 Oct; 66(5):61-69. PubMed ID: 33369373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.